Some considerations regarding the characterization and interpretation of neuropeptide-induced behavioral changes.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001562:Benzimidazoles / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004723:Endorphins / Q000494:pharmacology; D004745:Enkephalins / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D008691:Methadone / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009270:Naloxone / Q000494:pharmacology; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D001562:Benzimidazoles; D004723:Endorphins; D004745:Enkephalins; D010455:Peptides; D009270:Naloxone; D009020:Morphine; D006220:Haloperidol; D008691:Methadone